The COVID-19 pandemic may have led viewers to take a stronger
interest in a TV commercial advertising a treatment for HIV/AIDS, according to a focused study by media attribution startup Rslt.io.
The company found that a spot for Dovato, a drug made by ViiV Healthcare, drove 36% of the engagement …
Reminder: You are seeing this premium content because you are a subscriber to MediaPost's Research Intelligencer and/or a member of the Center for Marketing & Media Research. This content cannot be viewed by non-subscribers/non-members.